EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Chromatographic–mass spectrometric analysis of peptidic analytes (2–10 kDa) in doping control urine samples

Andreas Thomas iD, Katja Walpurgis, Mario Thevis

Journal of Mass Spectrometry · 2024

DOI: 10.1002/jms.4996 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Mass Spectrometry, 2024. Verfasst von Andreas Thomas und 2 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Biochemistry/Center for Preventive Doping Research, German Sport University Cologne, Cologne, Germany. Hauptthemen laut MEDLINE: Doping in Sports, Body Fluids. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Manfred Donike Institut für Dopinganalytik.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Peptides with a molecular mass between 2 and 10 kDa that are prohibited in elite sports usually require dedicated sample preparation and mass spectrometric detection that commonly cannot be combined with other (lower molecular mass) substances. In most instances, the physicochemical differences are too significant to allow for a generic analytical procedure. A simplification of established and comparably complex analytical approaches is therefore desirable and has been accomplished in the context of this study. With urine samples representing still the most frequently collected doping control specimens, efficient extraction of peptidic analytes from this matrix was a major goal of this method, as demonstrated for the included compounds such as insulins (human, lispro, aspart, glulisine, tresiba, glargine metabolite, bovine insulin, porcine insulin), growth hormone‐releasing hormones (sermorelin, CJC‐1295, tesamorelin) incl. their respective metabolites, insulin‐like‐growth factors (long‐R 3 ‐IGF‐I, R 3 ‐IGF‐I, des 1–3 ‐IGF‐I), synacthen, gonadorelin and mechano growth factors (human MGF, MGF‐Goldspink). Sample preparation and detection are controlled by five internal standards, covering all five included peptide drug categories. Nearly all requirements of the recent technical documents from the World Anti‐Doping Agency (WADA) considering their minimum required performance levels (MRPL) are fulfilled, and the method was validated for its utilisation as initial testing procedure in doping controls. Finally, the approach was applied to authentic post‐administration study urine samples (for insulins and gonadorelin) in order to provide proof of principle.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Doping in SportsBody FluidsHumansSwineAnimalsCattleInsulin-Like Growth Factor IGonadotropin-Releasing HormoneInsulin

Stichwörter der Autor:innen

peptide screeningsolid-phase extractionsports drug testing

Substanzen

Insulin-Like Growth Factor IGonadotropin-Releasing HormoneInsulin

Autor:innen und Institutionen

  • Institute of Biochemistry/Center for Preventive Doping Research, German Sport University Cologne, Cologne, Germany.
  • European Monitoring Center for Emerging Doping Agents (EuMoCEDA), Cologne/Bonn, Germany.

ORCID-Profile: Andreas Thomas

Förderung

  • Manfred Donike Institut für Dopinganalytik

Zitieren

APA

Thomas, A., Walpurgis, K., & Thevis, M. (2024). Chromatographic–mass spectrometric analysis of peptidic analytes (2–10 kDa) in doping control urine samples. Journal of Mass Spectrometry. https://doi.org/10.1002/jms.4996

Vancouver

Thomas A, Walpurgis K, Thevis M. Chromatographic–mass spectrometric analysis of peptidic analytes (2–10 kDa) in doping control urine samples. Journal of Mass Spectrometry. 2024. doi:10.1002/jms.4996

BibTeX
@article{Thomas2024,
  author = {Thomas, Andreas and Walpurgis, Katja and Thevis, Mario},
  title = {Chromatographic–mass spectrometric analysis of peptidic analytes (2–10 kDa) in doping control urine samples},
  journal = {Journal of Mass Spectrometry},
  year = {2024},
  doi = {10.1002/jms.4996}
}
Kostenlos starten →